Movement Alert|Astera Labs, Inc. Rises 3.41% in Pre-Market Trading, Q2 Earnings Beat Expectations with Q3 Guidance Far Exceeding Consensus

Market Focus
Aug 05

On August 5, Astera Labs, Inc. rose 3.41% in pre-market trading, trading at 374.5 USD/share, with turnover of $5.9225 million.

The stock's upward movement follows the company's Q2 earnings release after the prior session's close, which significantly exceeded market expectations on all fronts. Adjusted EPS came in at $0.80, well above the $0.69 consensus estimate, while revenue reached $392.4 million versus the $360.7 million expected, representing approximately 100% year-over-year growth. More critically, the company guided Q3 revenue to $540-$560 million, dramatically surpassing the prior Street consensus of $417 million, reflecting accelerating demand for AI infrastructure connectivity solutions.

Institutional sentiment has also turned decisively bullish. Morgan Stanley raised its price target from $240 to $335 while maintaining an Overweight rating, and Barclays lifted its target to $325, with both firms citing the company's strong positioning in the high-speed interconnect chip segment. Additionally, the company's Taurus smart cable module series is expected to benefit from potential demand spillover effects in the active electrical cable space driven by expanding AI compute buildouts.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10